Category: Replacement Heart ValvesSyndicate content

Heart Valves

Press Release: Boston Scientific receives CE Mark for the new 25 mm Lotus valve system

July 15, 2014 by MassDevice

European launch means physicians can now choose from three available valve sizes to match patient anatomy more precisely.

Press Release: Boston Scientific receives CE Mark for the new 25 mm Lotus valve system

Boston Scientific lands Euro approval for mid-size Lotus valve

July 15, 2014 by Arezu Sarvestani

Boston Scientific launches European sales of its 25 mm Lotus aortic valve, adding to the 23 mm and 27 mm valves already on the market.

Boston Scientific lands Euro approval for mid-size Lotus valve

Boston Scientific (NYSE:BSX) is heading straight to market with its 25 mm Lotus transcatheter aortic valve after winning CE Mark approval this week, the company announced.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Valve-in-valve surgery shows promise in new registry study

July 11, 2014 by Arezu Sarvestani

An new study shows that transcatheter aortic valve-in-valve implantation may be an important option for a growing population of patients with deteriorating bioprosthetic implants, but outcomes depend strongly on how the previous valve is failed.

Medtronic and Edwards implants show promise in valve-in-valve treatment

New research released this week provides more support for the use of transcatheter aortic valve-in-valve (VIV) implantation as a means of replacing previously implanted valves that have deteriorated over time.

More good news for Abbott's MitraClip in JACC study

July 11, 2014 by Arezu Sarvestani

Abbott's MitraClip implant reduces mitral regurgitation and improves quality of life at 1 year in high-risk patients, according to new study results from the Everest II clinical trial.

More good news for Abbott's MitraClip

High-risk patients with mitral regurgitation reduced their symptoms and reported better quality of life after treatment with Abbott's (NYSE:ABT) MitraClip implant, according to newly published results from the Everest II High Risk Registry.

Report: Stealthy Mvalve raises $15M from Boston Scientific

July 7, 2014 by Brad Perriello

Israeli heart valve maker Mvalve reportedly pulls in a $15 million investment from Boston Scientific in a deal that includes a $200 million buyout option.

Report: Stealthy Mvalve raises $15M from Boston Scientific

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

CardiAQ Valve claims European win in heart valve spat with Neovasc

July 7, 2014 by Brad Perriello

CardiAQ Valve Technologies says the European Patent Office put a hold on Neovasc's patent application covering replacement heart valve technology, after CardiAQ leveled infringement lawsuits in the U.S. and Germany.

CardiAQ Valve claims European win in heart valve spat with Neovasc

Study: Early CoreValve patients saw growing leakage, mortality risk

July 1, 2014 by Arezu Sarvestani

Valve leakage and cardiovascular mortality increased significantly over the course of a 3-year study of early high-risk patients treated with Medtronic's CoreValve TAVI system, but researchers insist the results are still "amazingly good."

Study: Early CoreValve patients plagued by side effects at 3 years
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp